Search - tctmd.com

Displaying 21 - 40 of 71

Sort: Relevancy | Date

Presentation JIM 2020

TSP Crosser Transseptal access device

Presenter: Federico De Marco

February 13, 2020

Presentation JIM 2020

Treatment of stable patients: pro and contra of functional (FFR-IFR) vs anatomical (IVUS-OCT) based strategy

Presenter: Laura Gatto

February 13, 2020

Presentation JIM 2020

Tips And Tricks In Retrograde CTO PCI

Presenter: Roberto Garbo

February 13, 2020

Presentation JIM 2020

The use of Allegra-Valve (NVT) in the Valve-in-Valve setting

Presenter: Ulrich Schafer

February 13, 2020

Presentation JIM 2020

The updated experience of the Tricento bioprosthesis for tricuspid regurgitation

Presenter: Ulrich Schaefer

February 13, 2020

Presentation JIM 2020

The Abluminus DES+: from the technical features to the clinical program

Presenter: Luca Testa

February 13, 2020

Presentation JIM 2020

Technical innovations in CTO

Presenter: Mauro Carlino

February 13, 2020

Presentation JIM 2020

Supraflex Cruz in the challenging scenario of older MI patients

Presenter: Gianluca Campo

February 13, 2020

Presentation JIM 2020

Present and future of resorbable magnesium scaffold. An expert review.

Presenter: Stefano Galli

February 13, 2020

Presentation JIM 2020

PCI in a NSTEMI patient When less is more…

Presenter: Baralis Giorgio

February 13, 2020

Presentation JIM 2020

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presenter: Marco Valgimigli

February 13, 2020

Presentation JIM 2020

Optimal LDL levels in patients with ACS undergoing PCI

Presenter: Giuseppe Musumeci

February 13, 2020

Presentation JIM 2020

Optimal LDL Levels In Patients With ACS Undergoing PCI Clinical Case: PCI In ACS Patients With Multivessel Disease

Presenter: Ferdinando Varbella

February 13, 2020

Presentation JIM 2020

Meeting the changing needs of TAVI patients - importance of hemodynamics and avoiding patient prosthesis mismatch

Presenter: Flavio Ribichini

February 13, 2020

Presentation JIM 2020

Long-term antithrombotic therapy in high-risk PCI patients

Presenter: Alberto Menozzi

February 13, 2020

Presentation JIM 2020

Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT

Presenter: Giuseppe Tarantini

February 13, 2020

Presentation JIM 2020

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Presenter: Marco Ferlini

February 13, 2020

Presentation JIM 2020

Innovations in PCI: Update in Drug Coated Balloon Technologies(Focus on Paclitaxel Toxicity)

Presenter: Juan Granada

February 13, 2020

Presentation JIM 2020

Drug-coated balloon vs. drug eluting stent for small coronary vessel disease: 6-mo. primary outcome of the PICCOLETO II randomized clinical trial.

Presenter: Bernardo Cortese

February 13, 2020

Presentation JIM 2020

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Presenter: Dominick Angiolillo

February 13, 2020

Advertisement

TSP Crosser Transseptal access device

Treatment of stable patients: pro and contra of functional (FFR-IFR) vs anatomical (IVUS-OCT) based strategy

Tips And Tricks In Retrograde CTO PCI

The use of Allegra-Valve (NVT) in the Valve-in-Valve setting

The updated experience of the Tricento bioprosthesis for tricuspid regurgitation

The Abluminus DES+: from the technical features to the clinical program

Technical innovations in CTO

Supraflex Cruz in the challenging scenario of older MI patients

Present and future of resorbable magnesium scaffold. An expert review.

PCI in a NSTEMI patient When less is more…

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Optimal LDL levels in patients with ACS undergoing PCI

Optimal LDL Levels In Patients With ACS Undergoing PCI Clinical Case: PCI In ACS Patients With Multivessel Disease

Meeting the changing needs of TAVI patients - importance of hemodynamics and avoiding patient prosthesis mismatch

Long-term antithrombotic therapy in high-risk PCI patients

Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Innovations in PCI: Update in Drug Coated Balloon Technologies(Focus on Paclitaxel Toxicity)

Drug-coated balloon vs. drug eluting stent for small coronary vessel disease: 6-mo. primary outcome of the PICCOLETO II randomized clinical trial.

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content